Hebei Mojin Biotechnology Co.,Ltd
Diamond Supplier Enterprise Certification
- Diamond
Supplier - 6th
years
Diamond Supplier Enterprise Certification
Product Certification&
Enterprise Certification
Country: 
China (Mainland)
Business Type:Trading Company
Tel: 13231137666
Tel: 15028179902
Tel: 13383610321
Tel: +86 13288715578
Tel: 13288715308
Tel: +86 15028179772
Tel: +86 13315458396
Tel: 15103291926
Tel: 13315457394
Mobile: 13231137666
Tel: 13231137666
Fax:
Province/state: Hebei
City: shijiazhuang
Street: room 1401,A building,Enjoy city,shijiazhuang city,hebei province,China
MaxCard:
Ms.betty Ms.mayCAS NO.82640-04-8
comestic(1-25)Kilogramcomestic(25-100)Kilogram
Hebei Mojin Biotechnology Co., Ltd,Our business covers more than 30 countries, most of the big customers come from Europe, America and other countries in the world, we can guarantee the quality and price. In recent decades, with the efforts of all employees, we have established many cooperative companies in shandong, henan, guangdong and other places. Our corporate purpose is based on the market, enhance the strength, take the road of scientific and environmental sustainable development, relying on the country. Technology r & d center, increase the investment in r & d, based on the domestic market, expand the international market, manufacturing quality products, sincere service to the society, into a modern, ecological, scientific and technological enterprise world.
Adenosine triphosphate can be used in the disease caused by tissue injury and activity reduction of ecto enzyme , including heart failure, carditis, miocardial infarction, cerebral arteriosclersis, coronary sclerosis, progressive muscular atrophy , cerebral hemorrhage , chronic hepatitis, cirrhosis of liver and hearing handicap, etc.
Product Detailed
| Product Name | Raloxifen e Hydrochloride |
| CAS NO. | 82640-04-8 |
| Other Name | Raloxifen e HCl |
| Molecular Formular | C28H28ClNO4S |
| Molecular Weight | 510.044 |
| Appearance | LIGHT YELLOW powder |
| Purity | 99% |
| Boiling Point | 728.2ºC at 760 mmHg |
| Meliting Point | 143-147ºC |
| Flash Point | 394.2ºC |
| Density | 1.285g/cm3 |
R'aloxifene Hydrochloride is an estrogen agonist/antagonist, referred to as a selective estrogen receptor modulator (SERM) and belongs to the benzothiophe class of compounds. The biological actions of R'aloxifene are largely mediated through binding to estrogen receptors. This binding results in activation of estrogenic pathways in some tissues (Agonism) and and the blockade of estrogenic pathways in other tissues (Antagonism).
Product Parameters
| ITEMS | SPECIFICATION | RESULT | |
| Appearance | Light Yellow Powder | Conform | |
| Solubility | Soluble in 10% sodium hydroxid solution. Slightly Soluble in meth anol. Insoluble in water | Conform | |
| Identifications | Infrared Absorption | Conform | |
| Chloride | Conform | ||
| Tests | Loss on drying | ≤0.5% | 0.4% |
| Residue on ignition | ≤0.1% | 0.06% | |
| Heavy metals | ≤10ppm | Conform | |
| Related substances | R'aloxifene Impurity1 | ≤0.20 % | 0.10% |
| Any unspecified individual impurity 2 | ≤0.10% | Max. 0.08% | |
| Total impurities | ≤0.50% | 0.40% | |
| Assay | R'aloxifene HCl | ≥98.0% | 99.0% |
Product Usage
(1) R'aloxifene is used to prevent and treat osteoporosis (condition in which the bones become thin and weak and break easily) in women who have undergone menopause (change of life; end of menstrual periods). R'aloxifene is also used to decrease the risk of developing invasive breast cancer (breast cancer that has spread outside of the milk ducts or lobules into the surrounding breast tissue) in women who are at high risk of developing this type of cancer or who have osteoporosis. R'aloxifene cannot be used to treat invasive breast cancer or to prevent invasive breast cancer from coming back in women who have already had the condition.
(2) R'aloxifene also cannot be used to decrease the risk of developing non-invasive breast cancer. R'aloxifene is in a class of medications called selective estrogen receptor modulators (SERMs). R'aloxifene prevents and treats osteoporosis by mimicking the effects of estrogen (a female hormone produced by the body) to increase the density (thickness) of bone. R'aloxifene decreases the risk of developing invasive breast cancer by blocking the effects of estrogen on breast tissue. This may stop the development of tumors that need estrogen to grow.
Product picture
Packing &shipping&Payment
Packing:25kg/drum
Shipping:by sea or by air
Payment:T/T,,moneygram
Packaging Details drum
Port:Tianjin
Lead Time :
| Quantity(Kilograms) | 1 - 10000 | >10000 |
| Est. Time(days) | 5 | To be negotiated |
Advantage
In stock